Technology
D2L Inc. Announces Third Quarter 2025 Financial Results
Published
2 years agoon
By
Subscription and support revenue grew 13% year-over-year to US$46.8 millionProfessional services and other revenue in the quarter increased to US$7.5 millionAnnual Recurring Revenue1 reached US$201.7 million, up 12% over the prior yearAdjusted EBITDA2 of US$10.4 million and Adjusted EBITDA margin2 of 19.2% margin in the quarterCompany increases Fiscal 2025 revenue guidance to $204 million to $205 million and increases Adjusted EBITDA guidance to $25.5 million to $26.5M million
TORONTO, Dec. 4, 2024 /CNW/ – D2L Inc. (TSX: DTOL) (“D2L” or the “Company”), a leading global learning technology company, today announced financial results for its Fiscal 2025 third quarter ended October 31, 2024. All amounts are in U.S. dollars and all figures are prepared in accordance with International Financial Reporting Standards (“IFRS”) unless otherwise indicated.
“Our strong third-quarter results were highlighted by healthy growth in subscription revenue and significant margin expansion, driving substantial improvement in our ‘Rule of 40’ performance as we successfully balance growth and market share gains with improving profitability,” said John Baker, CEO of D2L. “We continue to benefit from high win rates in our target markets as we navigate the broader macroeconomic conditions. We’re making disciplined investments that support our goal of long-term market leadership, and have seen strong customer response and pipeline generation from our recently expanded product portfolio, including our AI offering Lumi and Creator+. These new products make learning experiences better and easier to create for our customers, leading to improved learning outcomes and better learner retention.”
Third Quarter Fiscal 2025 Financial Highlights
Total revenue was $54.3 million, up 18% from the same period in the prior year.Subscription and support revenue was $46.8 million, an increase of 13% over the same period of the prior year.Professional services and other revenue was $7.5 million, an increase of $2.8 million from the same period of the prior year. During the current quarter, the Company recognized services revenue of $1.2 million from re-evaluating the completion progress of certain professional services engagements. Excluding this revenue, services revenue increased by $1.6 million over the prior year, and total revenue increased by $7.1 million or 15.2% year over year. Annual Recurring Revenue1 as at October 31, 2024 increased by 12% or $21.6 million year-over-year, from $180.1 million to $201.7 million.Cash flow from operating activities was $11.4 million, compared to $15.3 million in the same period in the prior year, and Free Cash Flow2 was $11.3 million, compared to $14.2 million in the same period in the prior year.Cash flow from operating activities for the 9-month period ended October 31, 2024 was $28.0 million, up 32% compared with $21.2 million for the same period in the prior year. Gross profit increased 22% to $37.4 million (68.9% gross profit margin) from $30.6 million (66.4% gross profit margin) in the same period of the prior year. Gross profit margin for subscription and support revenue increased to 72.7%, up 140 basis points from 71.3% in the same period of the prior year.Adjusted EBITDA2 increased to $10.4 million (19.2% Adjusted EBITDA margin2) from $2.1 million (4.6%) for the same period in the prior year. Excluding the additional services revenue of $1.2 million recognized in the quarter, Adjusted EBITDA and Adjusted EBITDA Margin would have been $9.2 million and 17.4%, respectively, for the three months ended October 31, 2024. Income for the period was $5.5 million, compared with a loss of $0.4 million for the comparative period of the prior year.Strong balance sheet at quarter end, with cash and cash equivalents of $108.3 million and no debt. During the third quarter, the Company repurchased and canceled 68,600 Subordinate Voting Shares under its normal course issuer bid (“NCIB”). The Company has repurchased and cancelled 348,080 shares since the inception of the NCIB on December 8, 2023.On December 4, 2024, the Company announced that the Toronto Stock Exchange (the “TSX”) accepted the Company’s notice to launch a new NCIB, commencing on December 9, 2024.
1 Refer to “Key Performance Indicators” section of this press release.
2 A non-IFRS financial measure or non-IFRS ratio. Refer to “Non IFRS Financial Measures” section of this press release.
Third Quarter Fiscal 2025 Financial Results – Selected Financial Measures
(in thousands of U.S. dollars, except for percentages)
Three months ended October 31
Nine months ended October 31
2024
2023
Change
Change
2024
2023
Change
Change
$
$
$
%
$
$
$
%
Subscription & Support Revenue
46,752
41,450
5,302
12.8 %
133,723
120,045
13,678
11.4 %
Professional Services & Other Revenue
7,547
4,663
2,884
61.8 %
18,240
14,766
3,474
23.5 %
Total Revenue
54,299
46,113
8,186
17.8 %
151,963
134,811
17,152
12.7 %
Constant Currency Revenue1
54,106
46,113
7,993
17.3 %
152,126
134,811
17,315
12.8 %
Gross Profit
37,390
30,600
6,790
22.2 %
103,441
90,161
13,280
14.7 %
Adjusted Gross Profit 1
37,964
30,778
7,186
23.3 %
104,439
90,622
13,817
15.2 %
Adjusted Gross Margin1
69.9 %
66.7 %
68.7 %
67.2 %
Income (Loss) for the period
5,547
(387)
5,934
1,533.3 %
5,857
(4,105)
9,962
242.7 %
Adjusted EBITDA1
10,420
2,122
8,298
391.0 %
18,652
4,399
14,253
324.0 %
Cash Flows From Operating Activities
11,420
15,318
(3,898)
(25.5 %)
28,037
21,171
6,866
32.4 %
Free Cash Flow1
11,296
14,244
(2,948)
(20.7 %)
27,567
16,009
11,558
72.2 %
1 A non-IFRS financial measure or non-IFRS ratio. Refer to the “Non-IFRS Financial Measures and Reconciliation of Non-IFRS Financial Measures” section of this press release for more details.
Third Quarter Business & Operating Highlights
D2L continued to grow its customer base in education in North America, including the additions of the Cincinnati State Technical and Community College, University of the Fraser Valley, and Prairie View A&M University.D2L continued to expand its international customer base, including XP Educação in Brazil and the main statutory body overseeing legal education and training in New Zealand.Signed new corporate customers, including Becoming Institute and the premier academic trauma surgery organization in the United States.Launched Creator+ natively integrated with H5P Group AS (“H5P”), offering an all-in-one solution for creating engaging courses with interactive content, video tools, dynamic analytics, and generative AI. Early adopters include the University of Hawaiʻi System.The Tambellini Group, the leading analyst and advisory firm focused on higher education, ranked D2L Brightspace highest among competitors for usability and innovation in the inaugural Tambellini StarChart™ 2024 for Learning Management Systems (“LMS”) in higher education.Named a winner in the 2024 LMS Top 20 Company by Training Industry and a winner in the 2024 Learning Systems Awards for Best Enterprise LMS by Talented Learning.D2L Lumi was named a winner of the Tech & Learning Awards of Excellence: Back to School 2024 in the Primary and Higher Education categories.Announced a strategic partnership with Seesaw, the leading elementary Learning Experience Platform to enhance the K-12 digital learning experience.
Financial Outlook
D2L updated its previously issued financial guidance for the year ended January 31, 2025 (“Fiscal 2025”) as follows:
Subscription and support revenue in the range of $180 million to $181 million, implying growth of 11% at the midpoint over Fiscal 2024, an increase from previously issued guidance of $178 million to $181 million;Total revenue in the range of $204 million to $205 million, implying growth of 12% at the midpoint over Fiscal 2024, an increase from previously issued guidance of $199 million to $202 million; andAdjusted EBITDA in the range of $25.5 million to $26.5 million, implying Adjusted EBITDA margin of 13% at the midpoint, an increase from previously issued guidance of $22 million to $24 million.
These guidance revisions reflect the Company’s continued progress in balancing revenue growth with operating efficiency improvements.
For additional details on the Company’s outlook, including the principal underlying assumptions and risk factors regarding achievement, refer to the “Financial Outlook” section of the Company’s Management’s Discussion and Analysis for the three and 12 months ended January 31, 2024 (the “Annual MD&A”), as well as the “Forward-Looking Information” section therein, below and in the Company’s Management’s Discussion and Analysis for the three months ended October 31, 2024 (the “Interim MD&A”).
Conference Call & Webcast
D2L management will host a conference call on Thursday, December 5, 2024 at 8:30 am ET to discuss its third quarter Fiscal 2025 financial results.
Date:
Thursday, December 5, 2024
Time:
8:30 am (ET)
Dial in number:
Canada/US: 1 (833) 470-1428
International: 1 (404) 975-4839
Access code: 027545
Webcast:
A live webcast will be available at ir.d2l.com/events-and-presentations/events/
The webcast will also be archived
Forward-Looking Information
This press release includes statements containing “forward-looking information” within the meaning of applicable securities laws. In some cases, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “budget”, “scheduled”, “estimates”, “outlook”, “target”, “forecasts”, “projection”, “potential”, “prospects”, “strategy”, “intends”, “anticipates”, “seek”, “believes”, “opportunity”, “guidance”, “aim”, “goal” or variations of such words and phrases or statements that certain future conditions, actions, events or results “may”, “could”, “would”, “should”, “might”, “will”, “can”, or negative versions thereof, “be taken”, “occur”, “continue” or “be achieved”, and other similar expressions. Statements containing forward-looking information are not historical facts, but instead represent management’s expectations, estimates and projections regarding future events or circumstances.
This forward-looking information relates to the Company’s future financial outlook and anticipated events or results and includes, but is not limited to, statements under the heading “Financial Outlook” and information regarding: the Company’s financial position, financial results, business strategy, performance, achievements, prospects, objectives, opportunities, business plans and growth strategies, including the Company’s balance growth and profitability plan; the Company’s budgets, operations and taxes; judgments and estimates impacting the financial statements; the markets in which the Company operates; industry trends and the Company’s competitive position; and expansion of the Company’s product offerings, including the impact of AI offerings on the Company’s addressable market and revenue opportunity.
Forward-looking information is based on certain assumptions, expectations and projections, and analyses made by the Company in light of management’s experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate, including the following: the Company’s ability to win business from new customers and expand business from existing customers; the timing of new customer wins and expansion decisions by existing customers; the Company’s ability to generate revenue and expand its business while controlling costs and expenses; the Company’s ability to manage growth effectively; the Company’s ability to hire and retain personnel effectively; the effects of foreign currency exchange rate fluctuations on our operations; the ability to seek out, enter into and successfully integrate acquisitions, including the acquisition of H5P; business and industry trends, including the success of current and future product development initiatives; positive social development and attitudes toward the pursuit of higher education; the Company’s ability to maintain positive relationships with its customer base and strategic partners; the Company’s ability to adapt and develop solutions that keep pace with continuing changes in technology, education and customer needs; the ability to patent new technologies and protect intellectual property rights; the Company’s ability to comply with security, cybersecurity and accessibility laws, regulations and standards; the assumptions underlying the judgments and estimates impacting on financial statements; and the Company’s ability to retain key personnel; the factors and assumptions discussed under the “Financial Outlook” section of the Annual MD&A, and that the list of factors referenced in the following paragraph, collectively, do not have a material impact on the Company.
Although the Company believes that the assumptions underlying such forward-looking information were reasonable when made, they are inherently uncertain and are subject to significant risks and uncertainties and may prove to be incorrect. The Company cautions investors that forward-looking information is not a guarantee of the future and that actual results may differ materially from those made in or suggested by the forward-looking information contained in this press release. Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to a number of known and unknown risks, uncertainties and other factors, including but not limited to the risks identified herein, or at “Summary of Factors Affecting Our Performance” of the Company’s Interim MD&A or in the “Risk Factors” section of the Company’s most recently filed annual information form, in each case filed under the Company’s profile on SEDAR+ at www.sedarplus.com. If any of these risks or uncertainties materialize, or if assumptions underlying the forward-looking information prove incorrect, actual results might vary materially from those anticipated in the forward-looking information.
Given these risks and uncertainties, investors are cautioned not to place undue reliance on forward-looking information, including any financial outlook. Any forward-looking information that is contained in this press release speaks only as of the date of such statement, and the Company undertakes no obligation to update any forward-looking information or to publicly announce the results of any revisions to any of those statements to reflect future events or developments, except as required by applicable securities laws. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless specifically expressed as such, and should only be viewed as historical data.
About D2L Inc. (TSX: DTOL)
D2L is transforming the way the world learns, helping learners achieve more than they dreamed possible. Working closely with customers all over the world, D2L is on a mission to make learning more inspiring, engaging and human. Find out how D2L helps transform lives and delivers outstanding learning outcomes in K-12, higher education and business at www.D2L.com.
D2L Inc.
Condensed Consolidated Interim Statements of Financial Position
(In U.S. dollars)
As at October 31, 2024 and January 31, 2024
(Unaudited)
October 31, 2024
January 31, 2024
Assets
Current assets:
Cash and cash equivalents
$ 108,252,331
$ 116,943,499
Trade and other receivables
20,379,489
23,025,690
Uninvoiced revenue
3,896,203
3,971,861
Prepaid expenses
6,559,188
10,517,226
Deferred commissions
5,134,323
5,334,864
144,221,534
159,793,140
Non-current assets:
Other receivables
480,621
537,056
Prepaid expenses
381,939
119,872
Deferred income taxes
573,268
529,674
Right-of-use assets
8,127,082
8,774,960
Property and equipment
7,402,295
8,427,734
Deferred commissions
7,449,801
7,730,724
Investment in associate
21,248
—
Loan receivable from associate
5,120,885
—
Intangible assets
18,073,003
770,707
Goodwill
26,379,860
10,440,091
Total assets
$ 218,231,536
$ 197,123,958
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable and accrued liabilities
$ 28,615,437
$ 32,635,926
Deferred revenue
105,842,166
93,727,368
Lease liabilities
1,396,079
1,002,464
Contingent consideration
4,893,539
271,479
140,747,221
127,637,237
Non-current liabilities:
Deferred income taxes
4,119,188
587,075
Lease liabilities
10,660,223
11,707,534
Contingent consideration
—
311,839
14,779,411
12,606,448
155,526,632
140,243,685
Shareholders’ equity:
Share capital
367,288,877
364,830,884
Additional paid-in capital
48,190,065
47,485,107
Accumulated other comprehensive loss
(7,333,643)
(4,998,317)
Deficit
(345,440,395)
(350,437,401)
62,704,904
56,880,273
Related party transactions
Subsequent event
Total liabilities and shareholders’ equity
$ 218,231,536
$ 197,123,958
D2L INC.
Condensed Consolidated Interim Statements of Comprehensive Income (Loss)
(In U.S. dollars)
For the three and nine months ended October 31, 2024 and 2023
(Unaudited)
Three months ended October 31
Nine months ended October 31
2024
2023
2024
2023
Revenue:
Subscription and support
$ 46,751,998
$ 41,449,926
$ 133,723,027
$ 120,045,266
Professional service and other
7,547,470
4,662,769
18,239,685
14,765,509
54,299,468
46,112,695
151,962,712
134,810,775
Cost of revenue:
Subscription and support
12,777,133
11,884,640
36,651,859
33,977,839
Professional services and other
4,132,232
3,627,638
11,870,394
10,671,456
16,909,365
15,512,278
48,522,253
44,649,295
Gross profit
37,390,103
30,600,417
103,440,459
90,161,480
Expenses:
Sales and marketing
12,806,266
12,807,855
40,302,476
40,209,601
Research and development
11,139,920
12,351,201
35,294,478
36,015,722
General and administrative
8,651,729
7,102,165
25,231,988
20,603,875
32,597,915
32,261,221
100,828,942
96,829,198
Income (loss) from operations
4,792,188
(1,660,804)
2,611,517
(6,667,718)
Interest and other income (expense):
Interest expense
(235,892)
(157,582)
(550,438)
(456,456)
Interest income
870,355
1,221,704
2,899,093
2,938,216
Other income (expense)
(122,043)
(10,355)
(122,000)
4,897
Gain on SkillsWave disposal transaction
—
—
917,395
—
Foreign exchange gain
224,145
314,938
307,859
380,417
736,565
1,368,705
3,451,909
2,867,074
Income (loss) before income taxes
5,528,753
(292,099)
6,063,426
(3,800,644)
Income taxes (recovery):
Current
246,162
43,883
602,830
435,294
Deferred
(264,457)
51,613
(396,134)
(130,838)
(18,295)
95,496
206,696
304,456
Income (loss) for the period
5,547,048
(387,595)
5,856,730
(4,105,100)
Other comprehensive gain (loss):
Foreign currency translation gain (loss)
137,532
(1,556,171)
(2,335,326)
(1,020,872)
Comprehensive income (loss)
$ 5,684,580
$ (1,943,766)
$ 3,521,404
$ (5,125,972)
Earnings (loss) per share – basic
$ 0.10
$ (0.01)
$ 0.11
$ (0.08)
Earnings (loss) per share – diluted
$ 0.10
$ (0.01)
$ 0.10
$ (0.08)
Weighted average number of common shares
– basic
54,453,244
53,703,768
54,282,281
53,454,498
Weighted average number of common shares
– diluted
56,032,694
53,703,768
55,828,067
53,454,498
D2L INC.
Condensed Consolidated Interim Statements of Shareholders’ Equity
(In U.S. dollars)
For the nine months ended October 31, 2024 and 2023
(Unaudited)
Share Capital
Additional
paid-in
capital
Accumulated
other
comprehensive
loss
Deficit
Total
Shares
Amount
Balance, January 31, 2024
53,978,085
$ 364,830,884
$ 47,485,107
$ (4,998,317)
$ (350,437,401)
$ 56,880,273
Issuance of Subordinate Voting Shares on
exercise of options
410,397
3,443,979
(1,804,429)
—
—
1,639,550
Issuance of Subordinate Voting Shares on
settlement of restricted share units
374,307
1,416,155
(4,602,395)
—
—
(3,186,240)
Stock-based compensation
—
—
7,111,782
—
—
7,111,782
Repurchase of share capital for
cancellation under NCIB
(306,880)
(2,402,141)
—
—
—
(2,402,141)
Change in share repurchase commitment
under ASPP
—
—
—
—
(859,724)
(859,724)
Other comprehensive loss
—
—
—
(2,335,326)
—
(2,335,326)
Income for the period
—
—
—
—
5,856,730
5,856,730
Balance, October 31, 2024
54,455,909
$ 367,288,877
$ 48,190,065
$ (7,333,643)
$ (345,440,395)
$ 62,704,904
Balance, January 31, 2023
53,146,530
357,639,824
46,084,161
(5,001,805)
(344,630,902)
54,091,278
Issuance of Subordinate Voting Shares on
exercise of options
381,794
3,414,019
(1,443,627)
—
—
1,970,392
Issuance of Subordinate Voting Shares on
settlement of restricted share units
218,010
988,410
(2,474,669)
—
—
(1,486,259)
Stock-based compensation
—
—
7,237,274
—
—
7,237,274
Other comprehensive loss
—
—
—
(1,020,872)
—
(1,020,872)
Loss for the period
—
—
—
—
(4,105,100)
(4,105,100)
Balance, October 31, 2023
53,746,334
$ 362,042,253
$ 49,403,139
$ (6,022,677)
$ (348,736,002)
$ 56,686,713
D2L INC.
Condensed Consolidated Interim Statements of Cash Flows
(In U.S. dollars)
For the nine months ended October 31, 2024 and 2023
(Unaudited)
2024
2023
Operating activities:
Income (loss) for the period
$ 5,856,730
$ (4,105,100)
Items not involving cash:
Depreciation of property and equipment
1,285,970
1,158,782
Depreciation of right-of-use assets
945,223
927,605
Amortization of intangible assets
723,100
60,159
Gain on disposal of property and equipment
(51,476)
(16,194)
Stock-based compensation
7,111,782
7,237,274
Net interest income
(2,348,655)
(2,481,760)
Income tax expense
206,696
304,456
Gain on SkillsWave disposal transaction
(917,395)
—
Loss from equity accounted investee
416,850
—
Fair value gain on loan receivable from associate
(120,885)
—
Changes in operating assets and liabilities:
Trade and other receivables
3,784,969
1,041,252
Uninvoiced revenue
(37,023)
(440,936)
Prepaid expenses
3,503,610
1,073,501
Deferred commissions
296,245
(1,105,606)
Accounts payable and accrued liabilities
(6,410,785)
1,952,832
Deferred revenue
11,573,770
13,243,128
Right-of-use assets and lease liabilities
(44,962)
(57,530)
Interest received
2,878,878
2,938,216
Interest paid
(19,343)
(9,815)
Income taxes paid
(596,646)
(549,475)
Cash flows from operating activities
28,036,653
21,170,789
Financing activities:
Payment of lease liabilities
(1,344,625)
(575,023)
Lease incentive received
103,128
935,025
Proceeds from exercise of stock options
1,639,550
1,970,392
Taxes paid on settlement of restricted share units
(3,186,240)
(1,486,259)
Repurchase of share capital for cancellation under NCIB
(2,402,141)
—
Cash flows (used in) from financing activities
(5,190,328)
844,135
Investing activities:
Purchase of property and equipment
(521,775)
(5,178,461)
Proceeds from disposal of property and equipment
51,476
16,537
Acquisition of business, net of cash acquired
(22,308,927)
(2,793,180)
Payment of contingent consideration
(249,436)
—
Transfer of cash on disposal of SkillsWave
(1,483,357)
—
Proceeds from sale of majority ownership stake in SkillsWave
809,038
—
Issuance of loan to SkillsWave
(5,000,000)
—
Cash flows used in investing activities
(28,702,981)
(7,955,104)
Effect of exchange rate changes on cash and cash equivalents
(2,834,512)
(1,701,358)
(Decrease) increase in cash and cash equivalents
(8,691,168)
12,358,462
Cash and cash equivalents, beginning of period
116,943,499
110,732,236
Cash and cash equivalents, end of period
$ 108,252,331
$ 123,090,698
Non-IFRS Financial Measures and Reconciliation of Non-IFRS Financial Measures
The information presented within this press release refers to certain non-IFRS financial measures (including non-IFRS ratios) including Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Gross Profit, Adjusted Gross Margin, Free Cash Flow, Free Cash Flow Margin, and Constant Currency Revenue. These measures are not recognized measures under IFRS and do not have a standardized meaning prescribed by IFRS. Non-IFRS financial measures should not be considered in isolation nor as a substitute for analysis of the Company’s financial information reported under IFRS and are unlikely to be comparable to similar measures presented by other issuers. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company’s results of operations, financial performance and liquidity from management’s perspective and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS measures. The Company believes that securities analysts, investors and other interested parties frequently use non-IFRS financial measures in the evaluation of the Company. The Company’s management also uses non-IFRS financial measures to facilitate operating performance comparisons from period to period, to prepare annual operating budgets and forecasts, and to assess our ability to meet our capital expenditures and working capital requirements.
Adjusted EBITDA and Adjusted EBITDA Margin
Adjusted EBITDA is defined as net income (loss), excluding interest, taxes, depreciation and amortization (or EBITDA), adjusted for stock-based compensation, foreign exchange gains and losses, non-recurring expenses, transaction-related costs, fair value adjustment of acquired deferred revenue, income (loss) from equity accounted investee, change in fair value on the loan receivable from associate, impairment charges and other income and losses. Adjusted EBITDA Margin is calculated as Adjusted EBITDA expressed as a percentage of total revenue. For an explanation of recent changes to and management’s use of Adjusted EBITDA and Adjusted EBITDA Margin see “Non-IFRS and Other Financial Measures – Non-IFRS Financial Measures and Non-IFRS Financial Ratios – Adjusted EBITDA and Adjusted EBITDA Margin” section in the Company’s Interim MD&A, which section is incorporated by reference herein.
The following table reconciles Adjusted EBITDA to income (loss) for the period, and discloses Adjusted EBITDA Margin, for the periods indicated:
(in thousands of U.S. dollars, except for percentages)
Three months ended October 31
Nine months ended October 31
2024
2023
2024
2023
Income (loss) for the period
5,547
(387)
5,857
(4,105)
Stock-based compensation
2,195
2,068
7,112
7,237
Foreign exchange gains
(224)
(315)
(308)
(380)
Non-recurring expenses(1)
305
807
2,171
957
Transaction-related costs(2)
1,249
169
2,072
721
Fair value adjustment of acquired deferred revenue
500
—
639
—
Change in fair value on loan receivable from
associate
(121)
—
(121)
—
Loss from equity accounted investee
320
—
417
—
Net interest income
(634)
(1,064)
(2,348)
(2,482)
Income tax (recovery) expense
(18)
95
207
304
Depreciation and amortization
1,301
749
2,954
2,147
Adjusted EBITDA
10,420
2,122
18,652
4,399
Adjusted EBITDA Margin
19.2 %
4.6 %
12.3 %
3.3 %
During the current quarter, the Company recognized services revenue of $1.2 million from re-evaluating the completion progress of certain professional services engagements. Excluding this increase, the Company’s Adjusted EBITDA and Adjusted EBITDA Margin would have been $9.2 million and 17.4%, respectively, for the three months ended October 31, 2024.
Notes:
(1)
These expenses relate to non-recurring activities, such as certain legal fees incurred that are not indicative of continuing operations, and changes of workforce or technology whereby certain functions were realigned to optimize operations.
(2)
These expenses include certain legal and professional fees that were incurred in connection with acquisition and other strategic transactions, including the disposal of our majority ownership stake in SkillsWave Corporation (“Skillswave”) and our acquisition of H5P. These expenses also include post-combination compensation costs from the acquisition of H5P. These expenses are net of a gain of $0.9 million recognized on the disposal of our majority ownership stake in SkillsWave. These expenses would not have been incurred if not for these transactions and are not considered expenses indicative of the Company’s continuing operations.
Adjusted Gross Profit and Adjusted Gross Margin
Adjusted Gross Profit is defined as gross profit excluding related stock-based compensation expenses and amortization from recently acquired intangible assets, specifically acquired technology. Adjusted Gross Margin is calculated as Adjusted Gross Profit expressed as a percentage of total revenue. For an explanation of management’s use of Adjusted Gross Profit and Adjusted Gross Margin see “Non-IFRS and Other Financial Measures – Non-IFRS Financial Measures and Non-IFRS Financial Ratios – Adjusted Gross Profit and Adjusted Gross Margin” section in the Company’s Interim MD&A, which section is incorporated by reference herein.
The following table reconciles Adjusted Gross Margin to gross profit expressed as a percentage of revenue, for the periods indicated:
(in thousands of U.S. dollars, except for
percentages)
Three months ended October 31
Nine months ended October 31
2024
2023
2024
2023
Gross profit for the period
37,390
30,600
103,441
90,161
Stock-based compensation
147
147
442
430
Acquired intangible asset amortization
427
31
556
31
Adjusted Gross Profit
37,964
30,778
104,439
90,622
Adjusted Gross Margin
69.9 %
66.7 %
68.7 %
67.2 %
During the current quarter, the Company recognized services revenue of $1.2 million from re-evaluating the completion progress of certain professional services engagements. Excluding this revenue, the Company’s Adjusted Gross Profit and Adjusted Gross Margin would have been $36.8 million and 69.2% respectively, for the three months ended October 31, 2024.
Free Cash Flow and Free Cash Flow Margin
Free Cash Flow is defined as cash provided by (used in) operating activities less net additions to property and equipment. Free Cash Flow Margin is calculated as Free Cash Flow expressed as a percentage of total revenue. For an explanation of management’s use of Free Cash Flow and Free Cash Flow Margin see “Non-IFRS and Other Financial Measures – Non-IFRS Financial Measures and Non-IFRS Financial Ratios – Free Cash Flow and Free Cash Flow Margin” section in the Company’s Interim MD&A, which section is incorporated by reference herein.
The following table reconciles our cash flow from (used in) operating activities to Free Cash Flow, and discloses Free Cash Flow Margin, for the periods indicated:
(in thousands of U.S. dollars, except for
percentages)
Three months ended October 31
Nine months ended October 31
2024
2023
2024
2023
Cash flow from operating activities
11,420
15,318
28,037
21,171
Net addition to property and equipment
(124)
(1,074)
(470)
(5,162)
Free Cash Flow
11,296
14,244
27,567
16,009
Free Cash Flow Margin
20.8 %
30.9 %
18.1 %
11.9 %
Constant Currency Revenue
Constant Currency Revenue is defined as foreign-currency-denominated revenues translated at the historical exchange rates from the comparable prior period into our U.S. dollar functional currency. For an explanation of management’s use of Constant Currency Revenue see “Non-IFRS and Other Financial Measures – Non-IFRS Financial Measures and Non-IFRS Financial Ratios – Constant Currency Revenue” section in the Company’s Interim MD&A, which section is incorporated by reference herein.
The following table reconciles our Constant Currency Revenue to revenue, for the periods indicated:
Three months ended October 31
Nine months ended October 31
(in thousands of U.S. dollars)
2024
2023
2024
2023
$
$
$
$
Total revenue for the period
54,299
46,113
151,963
134,811
(Positive) negative impact of foreign exchange rate
changes over the prior period
(193)
—
163
—
Constant Currency Revenue
54,106
46,113
152,126
134,811
During the current quarter, the Company recognized services revenue of $1.2 million from re-evaluating the completion progress of certain professional services engagements. Excluding this increase, the Company’s constant currency revenue would have been $52.9 million for the three months ended October 31, 2024.
Key Performance Indicators
Management uses a number of metrics, including the key performance indicators identified below, to help us evaluate our business, measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions. Our key performance indicators may be calculated in a manner different than similar key performance indicators used by other issuers. These metrics are estimated operating metrics and not projections, nor actual financial results, and are not indicative of current or future performance.
Annual Recurring Revenue and Constant Currency Annual Recurring Revenue: We define Annual Recurring Revenue as the annualized equivalent value of subscription revenue from all existing customer contracts as at the date being measured, exclusive of the implementation period. Our calculation of Annual Recurring Revenue assumes that customers will renew their contractual commitments as those commitments come up for renewal. We believe Annual Recurring Revenue provides a reasonable, real-time measure of performance in a subscription-based environment and provides us with visibility for potential growth to our cash flows. We believe that increasing Annual Recurring Revenue indicates the continued strength in the expansion of our business, and will continue to be our focus on a go-forward basis. We define Constant Currency Annual Recurring Revenue as foreign-currency-denominated Annual Recurring Revenue translated at the historical exchange rates from the comparable prior period into our U.S. dollar functional currency.
As at October 31
(in millions of U.S. dollars, except percentages)
2024
2023
Change
$
$
%
Annual Recurring Revenue
201.7
180.1
12.0 %
Constant Currency Annual Recurring Revenue
200.7
180.1
11.4 %
SOURCE D2L Inc.
You may like
Technology
Improve Cell Line Stability From Cloning to GMP Manufacturing, Upcoming Webinar Hosted by Xtalks
Published
37 minutes agoon
October 21, 2026By
In this free webinar, learn how early cell-development decisions can affect cell line stability from cloning through GMP manufacturing. The featured speakers will discuss culture conditions, clone selection, cellular stress, recloning and genetic integrity monitoring, using iPSC development as a key application. Attendees will also explore how image-verified cloning and stronger upstream workflows can support reproducibility, scalable manufacturing and GMP-ready cell banks.
TORONTO, Oct. 21, 2026 /PRNewswire/ — Maintaining cell line stability becomes increasingly important as programs move from early clone development toward scale-up, cell banking and GMP manufacturing. Variability introduced during cloning, culture and expansion can affect genetic integrity, reproducibility and confidence in the cells being carried forward. Using iPSC development as a key application, this webinar will explore how early workflow decisions can help identify and reduce these risks before they impact downstream manufacturing.
The featured panelists will explore how decisions made during clone establishment and early cell development can influence long-term cellular stability. The discussion will examine how culture conditions, media and matrix selection and cellular stress can affect clonal outgrowth and contribute to genetic drift, as well as how stronger clone-selection and monitoring strategies can help reduce these risks.
Using iPSC development as a key application, the speakers will demonstrate how single-cell cloning, image-verified clone selection and automated clonal outgrowth monitoring can provide greater confidence and traceability during cell development. They will also explore when recloning may be appropriate, how genetic integrity can be monitored at key stages and how these approaches can support the creation of robust, well-characterized cell banks.
The session will connect early cell-development decisions with broader goals including reproducibility, scalability, genetic integrity, manufacturing readiness and the development of well-characterized GMP-ready cell banks, giving practical considerations for building more reliable workflows.
Attendees will gain insight into how to recognize sources of clonal variability, strengthen clone-selection strategies, maintain confidence in genetic stability and reduce the risk of carrying early development problems into later stages.
Register for this webinar to learn how cell line stability can be strengthened through clone selection, genetic integrity monitoring and cell-development strategies that support scalable manufacturing.
Join Noud Drummen, Field Application Scientist, Nova Biomedical; and Silvia Rosati, Research Scientist, Process Development Lab, Evotec (Modena), for the live webinar on Thursday, October 29, 2026, at 11am EDT (4pm CET / EU-Central).
For more information, or to register for this event, visit Improve Cell Line Stability From Cloning to GMP Manufacturing.
ABOUT XTALKS
Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what’s next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: skumar@xtalks.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/improve-cell-line-stability-from-cloning-to-gmp-manufacturing-upcoming-webinar-hosted-by-xtalks-302915898.html
SOURCE Xtalks
Technology
Lam Research Corporation Reports Financial Results for the Quarter Ended September 27, 2026
Published
37 minutes agoon
October 21, 2026By
FREMONT, Calif., Oct. 21, 2026 /PRNewswire/ — Lam Research Corporation (the “Company,” “Lam,” “Lam Research”) today announced financial results for the quarter ended September 27, 2026 (the “September 2026 quarter”).
Highlights for the September 2026 quarter were as follows:
Revenue of $8.22 billion.U.S. GAAP gross margin as a percent of revenue of 52.3%, U.S. GAAP operating margin as a percent of revenue of 40.0%, and U.S. GAAP diluted EPS of $2.19.Non-GAAP gross margin as a percent of revenue of 52.4%, non-GAAP operating margin as a percent of revenue of 40.2%, and non-GAAP diluted EPS of $2.20.
Key Financial Data for the Quarters Ended
September 27, 2026 and June 28, 2026
(in thousands, except per share data, percentages, and basis points)
U.S. GAAP
September 2026
June 2026
Change Q/Q
Revenue
$ 8,219,418
$ 6,722,238
+22 %
Gross margin
52.3 %
51.7 %
+ 60 bps
Operating margin
40.0 %
37.4 %
+ 260 bps
Diluted EPS
$ 2.19
$ 1.81
+ 21 %
Non-GAAP
September 2026
June 2026
Change Q/Q
Revenue
$ 8,219,418
$ 6,722,238
+22 %
Gross margin
52.4 %
52.0 %
+ 40 bps
Operating margin
40.2 %
38.4 %
+ 180 bps
Diluted EPS
$ 2.20
$ 1.82
+ 21 %
U.S. GAAP Financial Results
For the September 2026 quarter, revenue was $8.22 billion, gross margin was $4.30 billion, or 52.3% of revenue, operating expenses were $1.02 billion, operating margin was 40.0%, and net income was $2.75 billion, or $2.19 per diluted share on a U.S. GAAP basis. This compares to revenue of $6.72 billion, gross margin of $3.48 billion, or 51.7% of revenue, operating expenses of $965.3 million, operating margin of 37.4%, and net income of $2.28 billion, or $1.81 per diluted share, for the quarter ended June 28, 2026 (the “June 2026 quarter”).
Non-GAAP Financial Results
For the September 2026 quarter, non-GAAP gross margin was $4.31 billion, or 52.4% of revenue, non-GAAP operating expenses were $1.00 billion, non-GAAP operating margin was 40.2%, and non-GAAP net income was $2.77 billion, or $2.20 per diluted share. This compares to non-GAAP gross margin of $3.50 billion, or 52.0% of revenue, non-GAAP operating expenses of $916.4 million, non-GAAP operating margin of 38.4%, and non-GAAP net income of $2.28 billion, or $1.82 per diluted share, for the June 2026 quarter.
“With AI driving higher semiconductor demand and greater device complexity, our focus on operational execution helped Lam deliver record revenue, profit, and earnings per share in the September quarter,” said Tim Archer, Lam Research’s President and Chief Executive Officer. “Our strategic investments in technology inflections and manufacturing capacity are paying off, strengthening our ability to outgrow the wafer fabrication equipment market as the industry expands.”
Balance Sheet and Cash Flow Results
Cash, cash equivalents, and restricted cash balances increased to $7.45 billion at the end of the September 2026 quarter compared to $5.60 billion at the end of the June 2026 quarter. The increase was primarily the result of cash generated from operating activities during the quarter partially offset by cash deployed for capital return activities and capital expenditures.
Deferred revenue at the end of the September 2026 quarter increased to $2.66 billion compared to $2.43 billion as of the end of the June 2026 quarter. Lam’s deferred revenue balance does not include shipments to customers in Japan, to whom control does not transfer until customer acceptance. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $468.3 million as of September 27, 2026 and $490.2 million as of June 28, 2026.
Revenue
The geographic distribution of revenue during the September 2026 quarter is shown in the following table:
Region
Revenue
China
35 %
Korea
20 %
Taiwan
18 %
Japan
9 %
United States
8 %
Southeast Asia
6 %
Europe
4 %
The following table presents revenue disaggregated between systems and customer support-related revenue:
Three Months Ended
September 27,
2026
June 28,
2026
September 28,
2025
(in thousands)
Systems revenue
$ 5,732,907
$ 4,249,848
$ 3,547,565
Customer support-related revenue and other
2,486,511
2,472,390
1,776,608
$ 8,219,418
$ 6,722,238
$ 5,324,173
Systems revenue includes sales of new leading-edge equipment in deposition, etch, clean, and other wafer fabrication markets.
Customer support-related revenue includes sales of customer services, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.
Outlook
For the quarter ending December 27, 2026, Lam is providing the following guidance:
U.S. GAAP
Reconciling Items
Non-GAAP
Revenue
$8.60 Billion
+/-
$400 Million
—
$8.60 Billion
+/-
$400 Million
Gross margin
52.5 %
+/-
1 %
$ 2.7
Million
52.5 %
+/-
1 %
Operating margin
40.5 %
+/-
1 %
$ 3.0
Million
40.5 %
+/-
1 %
Net income per diluted share
$2.33
+/-
$0.15
$ 3.3
Million
$2.33
+/-
$0.15
Diluted share count
1.253 Billion
—
1.253 Billion
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other items that may be completed or realized after the date of this release, except as described below. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:
Gross margin – amortization related to intangible assets acquired through certain business combinations, $2.7 million.Operating margin – amortization related to intangible assets acquired through certain business combinations, $3.0 million.Net income per diluted share – amortization related to intangible assets acquired through certain business combinations, $3.0 million; amortization of note discounts, $0.5 million; and associated tax benefit for non-GAAP items ($0.2 million); totaling $3.3 million.
Use of Non-GAAP Financial Results
In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the September 2026 and June 2026 quarters exclude amortization related to intangible assets acquired through certain business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, and the net income tax effect of non-GAAP items. The September 2026 quarter also excludes the net income tax effect of a change in tax law, and the June 2026 quarter excludes workforce optimization charges and the related income tax effect.
Management uses non-GAAP gross margin, operating expense, operating income, operating margin, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at https://investor.lamresearch.com.
Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning: our outlook and guidance for future financial results, including revenue, gross margin, operating margin, net income per diluted share, and diluted share count; AI-driven semiconductor demand and device complexity; our focus on operational execution; the perceived benefits of our strategic investments; our ability to outgrow the wafer fabrication equipment market as the industry expands; and deferred revenue. These statements are not a guarantee of future performance and involve a number of risks, uncertainties, and other factors that could cause our actual results or outcomes, or the timing of our results or outcomes, to differ materially from those expressed or implied in this press release. Such risks, uncertainties, and other factors include: our assumptions related to continued expansion of the wafer fabrication equipment market, growth of deposition and etch intensity, and scaling of our operations may prove invalid; business, economic, political, and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy, including wafer fabrication equipment spending or demand related to AI, may deteriorate or change; the actions, performance, or investment levels of our customers and competitors may be inconsistent with our expectations; customer and product mix, including across market segments and geographical regions, may change; we may be unable to realize the value of our products and technology, successfully commercialize new products and technologies, implement pricing initiatives, or execute on perceived opportunities; we may be unable to achieve anticipated operational, manufacturing, supply chain, procurement, and scale efficiencies; customer technology transitions, capacity expansions, and fab construction projects may have different timing or be less successful than we expect; we may be unable to manage operating expenses effectively while continuing to invest in research and development, product innovation, customer support, and future growth opportunities; trade regulations, export controls (including entity listings, end use/user controls, technology controls, and foreign direct product rules), tariffs, trade disputes, and other geopolitical developments may inhibit our ability to sell our products or services; supply chain cost increases, tariffs, and other inflationary pressures may continue to impact our profitability; supply chain disruptions or manufacturing capacity constraints may limit our ability to manufacture and sell our products; natural and human-caused disasters, disease outbreaks, war, terrorism, political or governmental unrest or instability, or other events beyond our control may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the “Risk Factors” described in our most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. You should evaluate all forward-looking statements made in this press release in the context of these risks, uncertainties, and other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on our current beliefs, expectations, and assumptions about future events. Except as required by law, we undertake no obligation to update the information or statements made in this press release.
Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam’s equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX)
Condensed Consolidated Financial Tables Follow.
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
(unaudited)
Three Months Ended
September 27,
2026
June 28,
2026
September 28,
2025
Revenue
$ 8,219,418
$ 6,722,238
$ 5,324,173
Cost of goods sold
3,920,565
3,243,498
2,639,294
Gross margin
4,298,853
3,478,740
2,684,879
Gross margin as a percent of revenue
52.3 %
51.7 %
50.4 %
Research and development
666,398
642,922
576,446
Selling, general and administrative
348,728
322,330
279,345
Total operating expenses
1,015,126
965,252
855,791
Operating income
3,283,727
2,513,488
1,829,088
Operating margin
40.0 %
37.4 %
34.4 %
Other income (expense), net
28,493
41,654
30,074
Income before income taxes
3,312,220
2,555,142
1,859,162
Income tax expense
(559,082)
(277,860)
(290,502)
Net income
$ 2,753,138
$ 2,277,282
$ 1,568,660
Net income per share:
Basic
$ 2.20
$ 1.82
$ 1.24
Diluted
$ 2.19
$ 1.81
$ 1.24
Number of shares used in per share calculations:
Basic
1,250,883
1,251,286
1,264,446
Diluted
1,255,768
1,256,032
1,269,313
Cash dividend declared per common share
$ 0.33
$ 0.26
$ 0.26
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
September 27,
2026
June 28,
2026
September 28,
2025
(unaudited)
(1)
(unaudited)
ASSETS
Cash and cash equivalents
$ 7,437,384
$ 5,579,171
$ 6,693,046
Accounts receivable, net
5,658,379
5,339,682
3,633,034
Inventories
4,550,544
4,276,111
4,095,054
Prepaid expenses and other current assets
477,805
415,741
385,580
Total current assets
18,124,112
15,610,705
14,806,714
Property and equipment, net
3,126,029
2,956,472
2,510,531
Goodwill and intangible assets
1,911,547
1,895,859
1,826,950
Other assets
3,191,368
3,066,707
2,756,016
Total assets
$ 26,353,056
$ 23,529,743
$ 21,900,211
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt and finance lease obligations
$ 3,486
$ 4,073
$ 754,363
Other current liabilities
7,309,013
5,933,176
5,953,547
Total current liabilities
7,312,499
5,937,249
6,707,910
Long-term debt and finance lease obligations
3,731,958
3,730,490
3,729,580
Income taxes payable
684,273
681,197
646,044
Other long-term liabilities
715,852
709,886
623,925
Total liabilities
12,444,582
11,058,822
11,707,459
Stockholders’ equity (2)
13,908,474
12,470,921
10,192,752
Total liabilities and stockholders’ equity
$ 26,353,056
$ 23,529,743
$ 21,900,211
(1)
Derived from audited financial statements.
(2)
Common shares issued and outstanding were 1,249,145 as of September 27, 2026, 1,251,278 as of June 28, 2026, and 1,259,176 as of September 28, 2025.
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)
Three Months Ended
September 27,
2026
June 28,
2026
September 28,
2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income
$ 2,753,138
$ 2,277,282
$ 1,568,660
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
122,072
119,642
101,644
Deferred income taxes
(55,300)
(175,752)
(62,875)
Equity-based compensation expense
114,696
103,985
97,241
Other, net
27,633
(8,006)
(1,890)
Changes in operating assets and liabilities
535,413
(859,923)
76,184
Net cash provided by operating activities
3,497,652
1,457,228
1,778,964
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets
(257,697)
(188,801)
(185,121)
Other, net
(9,292)
45,060
(927)
Net cash used for investing activities
(266,989)
(143,741)
(186,048)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt, including finance lease obligations and payments for debt issuance costs
(34,489)
(1,355)
(1,417)
Treasury stock purchases, including excise tax payments
(1,024,965)
(246,560)
(975,791)
Dividends paid
(325,402)
(325,318)
(291,981)
Reissuance of treasury stock related to employee stock purchase plan
—
88,780
—
Proceeds from issuance of common stock, net of issuance costs
4,263
4,426
—
Other, net
(1,786)
(282)
(12,449)
Net cash used for financing activities
(1,382,379)
(480,309)
(1,281,638)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
4,663
(2,056)
(7,059)
Net change in cash, cash equivalents, and restricted cash
1,852,947
831,122
304,219
Cash, cash equivalents, and restricted cash at beginning of period (1)
5,597,943
4,766,821
6,407,656
Cash, cash equivalents, and restricted cash at end of period (1)
$ 7,450,890
$ 5,597,943
$ 6,711,875
(1)
Restricted cash is reported within Other assets in the Condensed Consolidated Balance Sheets.
Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
Three Months Ended
September 27,
2026
June 28,
2026
Revenue
$ 8,219,418
$ 6,722,238
Gross margin
$ 4,305,019
$ 3,497,336
Gross margin as a percent of revenue
52.4 %
52.0 %
Operating expenses
$ 1,004,280
$ 916,420
Operating income
$ 3,300,739
$ 2,580,916
Operating margin
40.2 %
38.4 %
Net income
$ 2,768,417
$ 2,279,968
Net income per diluted share
$ 2.20
$ 1.82
Shares used in per share calculation – diluted
1,255,768
1,256,032
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited)
Three Months Ended
September 27,
2026
June 28,
2026
U.S. GAAP net income
$ 2,753,138
$ 2,277,282
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations – cost of goods sold
2,668
2,668
Elective deferred compensation (“EDC”) related liability valuation increase – cost of goods sold
3,498
15,379
Workforce optimization charges – cost of goods sold
—
549
EDC related liability valuation increase – research and development
6,299
27,682
Workforce optimization charges – research and development
—
960
Amortization related to intangible assets acquired through certain business combinations – selling, general and administrative
348
348
EDC related liability valuation increase – selling, general and administrative
4,199
18,454
Workforce optimization charges – selling, general and administrative
—
1,388
Amortization of note discounts – other income (expense), net
508
504
Gain on EDC related asset – other income (expense), net
(12,870)
(61,325)
Net income tax benefit on non-GAAP items
(825)
(3,921)
Income tax expense from a change in tax law
11,454
—
Non-GAAP net income
$ 2,768,417
$ 2,279,968
Non-GAAP net income per diluted share
$ 2.20
$ 1.82
U.S. GAAP net income per diluted share
$ 2.19
$ 1.81
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation
1,255,768
1,256,032
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin,
Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited)
Three Months Ended
September 27,
2026
June 28,
2026
U.S. GAAP gross margin
$ 4,298,853
$ 3,478,740
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations
2,668
2,668
EDC related liability valuation increase
3,498
15,379
Workforce optimization charges
—
549
Non-GAAP gross margin
$ 4,305,019
$ 3,497,336
U.S. GAAP gross margin as a percent of revenue
52.3 %
51.7 %
Non-GAAP gross margin as a percent of revenue
52.4 %
52.0 %
U.S. GAAP operating expenses
$ 1,015,126
$ 965,252
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations
(348)
(348)
EDC related liability valuation increase
(10,498)
(46,136)
Workforce optimization charges
—
(2,348)
Non-GAAP operating expenses
$ 1,004,280
$ 916,420
U.S. GAAP operating income
$ 3,283,727
$ 2,513,488
Non-GAAP operating income
$ 3,300,739
$ 2,580,916
U.S. GAAP operating margin
40.0 %
37.4 %
Non-GAAP operating margin
40.2 %
38.4 %
Lam Research Corporation Contacts:
Ram Ganesh, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/lam-research-corporation-reports-financial-results-for-the-quarter-ended-september-27-2026-302915810.html
SOURCE Lam Research Corporation
Technology
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON NOVEMBER 4, 2026
Published
37 minutes agoon
October 21, 2026By
SALT LAKE CITY, Oct. 21, 2026 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced it will report its third quarter fiscal year 2026 financial results on Wednesday, November 4, 2026, after market close. The Company will host a corresponding conference call and live webcast to discuss operational highlights, financial results and key topics at 5:00 p.m. Eastern Time. A press release outlining the financial results and highlights will be publicly distributed before the call.
Conference Call Details:
US domestic callers: (800) 836-8184
International callers: (646) 357-8785
Webcast Registration Link: https://app.webinar.net/wK8exGQrE0B
Live audio of the webcast will be available on the Investors page of the Company’s website at www.sera.com. The webcast will be archived on the Investors page and will be available for one year.
About Sera Prognostics, Inc.
Sera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera’s mission is to provide early, pivotal pregnancy information to improve the health of mothers and newborns, resulting in reductions in the costs of healthcare delivery. Sera has a robust pipeline of innovative diagnostic tests focused on the early prediction of preterm birth risk and other complications of pregnancy. Sera’s precision medicine PreTRM® Test reports to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with higher risk. Sera Prognostics is headquartered in Salt Lake City, Utah.
About Preterm Birth
Preterm birth is defined as any birth before 37 weeks’ gestation and is the leading cause of illness and death in newborns. The 2025 March of Dimes Report Card shows that, for the fourth consecutive year, the United States earned a D+ grade for preterm birth, marking the longest stretch of the lowest grade in Report Card history. Prematurity is associated with a significantly increased risk of major long-term medical complications, including learning disabilities, cerebral palsy, chronic respiratory illness, intellectual disability, seizures, and vision and hearing loss, and can generate significant costs throughout the lives of affected children. The annual health care costs to manage short- and long-term complications of prematurity in the United States were estimated to be approximately $25 billion for 2016.
About the PreTRM® Test
The PreTRM® Test is the only broadly validated, commercially available blood-based biomarker test that provides an early, accurate and individualized risk prediction for spontaneous preterm birth in asymptomatic singleton pregnancies. The PreTRM® Test measures and analyzes proteins in the blood that are highly predictive of preterm birth. The PreTRM® Test permits physicians to identify, during the weeks 18 through 20 of pregnancy, which women are at increased risk for preterm birth and its complications, enabling more informed, personalized clinical decisions based on each woman’s individual risk. The PreTRM® Test is ordered by a medical professional.
Sera, Sera Prognostics, the Sera Prognostics logo, The Pregnancy Company, and PreTRM are trademarks or registered trademarks of Sera Prognostics, Inc. in the United States and/or other countries.
Safe Harbor Statement
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the date, time and content of the Company’s quarterly earnings release and conference call; availability of the live audio of the conference call on the Company’s website; and the Company’s strategic directives under the caption “About Sera Prognostics, Inc.” These “forward-looking statements” are based on management’s current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by forward-looking statements. These risks and uncertainties include, but are not limited to: net losses, cash generation, and the potential need to raise more capital; revenues from the PreTRM Test representing substantially all Company revenues to date; the need for broad scientific and market acceptance of the PreTRM Test; a concentrated number of material customers; our ability to introduce new products; potential competition; our proprietary biobank; critical suppliers; estimates of total addressable market opportunity and forecasts of market growth; potential third-party payer coverage and reimbursement; new reimbursement methodologies applicable to the PreTRM Test, including new CPT codes and payment rates for those codes; changes in FDA regulation of laboratory-developed tests; the intellectual property rights protecting our tests and market position; and other factors discussed under the heading “Risk Factors” contained in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission, as well as any updates to those risk factors filed from time to time in our periodic and current reports filed with the Securities and Exchange Commission. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information unless required by law.
Investor Contact
Jennifer Zibuda, Head of Investor Relations
jzibuda@sera.com
+1 (801) 396-8043
View original content to download multimedia:https://www.prnewswire.com/news-releases/sera-prognostics-announces-conference-call-and-webcast-of-third-quarter-fiscal-year-2026-financial-results-on-november-4-2026-302915767.html
SOURCE Sera Prognostics, Inc.
Improve Cell Line Stability From Cloning to GMP Manufacturing, Upcoming Webinar Hosted by Xtalks
Lam Research Corporation Reports Financial Results for the Quarter Ended September 27, 2026
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON NOVEMBER 4, 2026
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology4 days agoHighland and Bath Counties, Virginia Go Live on a Shared Caliber Hosted CAD Environment
-
Technology4 days agoJinkoSolar Unveils Tiger Neo 5.0 All-Black Residential Solar Module with 25.52% Efficiency
-
Near Videos5 days agoWhat if you could build a skyscraper with one prompt?
-
Technology4 days agoBioethanol from human hair – Indian start-up’s solution to rising prices of grains and sugar
-
Technology3 days agoGMIF2026: AI Inference Powers the “Token Factory” and Drives System-Level Rethinking of Memory & Storage
-
Technology3 days agoLinktel Technologies Highlights Breakthrough 1.6T LPO Performance & Strong Market Pull at OCP 2026
-
Technology3 days agoTruecaller announces preliminary numbers for the third quarter 2026
-
Coin Market2 days agoWorld Liberty’s USD1 stablecoin sheds $400M in market cap in two weeks
